Every SEC Form 3/4/5 on record for this filer (CIK 1278219) — 7 issuers, 18 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | Director | 2023-12-19 → 2026-06-17 | 5 | — |
| INO | INOVIO PHARMACEUTICALS, INC. | Director | 2019-01-04 → 2026-05-21 | 16 | −$37,783 |
| FFIN | FIRST FINANCIAL BANKSHARES INC | Director | 2026-05-05 → 2026-05-05 | 2 | — |
| ETNB | 89bio, Inc. | Director | 2020-06-04 → 2025-10-30 | 8 | — |
| ZYME | Zymeworks Inc. | Director · lapsed | 2019-01-02 → 2022-12-23 | 5 | — |
| ONCE | Spark Therapeutics, Inc. | CHIEF SCIENTIFIC OFFICER · Director · lapsed | 2016-01-08 → 2019-12-17 | 7 | — |
| OREX | Orexigen Therapeutics, Inc. | Director · lapsed | 2016-07-14 → 2017-07-18 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| INO | 2023-06-05 | Sell | 5,700 | $0.56 | $3,192 | 52,716 |
| INO | 2022-05-16 | Sell | 3,600 | $1.98 | $7,128 | 39,416 |
| INO | 2022-01-05 | Sell | 961 | $5.01 | $4,815 | 25,016 |
| INO | 2021-05-17 | Sell | 2,045 | $6.62 | $13,538 | 21,887 |
4 of 7 issuers are covered and open a security page; the rest are on file here only.
